DK0676413T3 - Inteferon-alfa/beta-bindingsprotein, dets fremstilling og anvendelse - Google Patents

Inteferon-alfa/beta-bindingsprotein, dets fremstilling og anvendelse

Info

Publication number
DK0676413T3
DK0676413T3 DK95101560T DK95101560T DK0676413T3 DK 0676413 T3 DK0676413 T3 DK 0676413T3 DK 95101560 T DK95101560 T DK 95101560T DK 95101560 T DK95101560 T DK 95101560T DK 0676413 T3 DK0676413 T3 DK 0676413T3
Authority
DK
Denmark
Prior art keywords
preparation
binding protein
beta binding
alpha
interferon
Prior art date
Application number
DK95101560T
Other languages
English (en)
Inventor
Batya Cohen
Daniela Novick
Menachem Rubinstein
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Application granted granted Critical
Publication of DK0676413T3 publication Critical patent/DK0676413T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK95101560T 1994-02-07 1995-02-06 Inteferon-alfa/beta-bindingsprotein, dets fremstilling og anvendelse DK0676413T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL108584A IL108584A (en) 1994-02-07 1994-02-07 Cloning of interferon -alpha/beta binding protein
EP95101560A EP0676413B9 (en) 1994-02-07 1995-02-06 Interferon-alpha/beta binding protein, its preparation and use

Publications (1)

Publication Number Publication Date
DK0676413T3 true DK0676413T3 (da) 2005-05-09

Family

ID=11065792

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95101560T DK0676413T3 (da) 1994-02-07 1995-02-06 Inteferon-alfa/beta-bindingsprotein, dets fremstilling og anvendelse

Country Status (17)

Country Link
EP (1) EP0676413B9 (da)
JP (2) JP3670045B2 (da)
KR (1) KR100382628B1 (da)
CN (1) CN1286976C (da)
AT (1) ATE286509T1 (da)
AU (1) AU688430B2 (da)
CA (1) CA2141747C (da)
DE (1) DE69533905T2 (da)
DK (1) DK0676413T3 (da)
ES (1) ES2236696T3 (da)
FI (1) FI118084B (da)
IL (1) IL108584A (da)
NO (1) NO318912B1 (da)
PT (1) PT676413E (da)
RU (4) RU2232811C2 (da)
UA (1) UA46694C2 (da)
ZA (1) ZA95968B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL118096A0 (en) * 1996-05-01 1996-09-12 Yeda Res & Dev Antibodies against interferon alpha/beta receptor
US7087726B2 (en) * 2001-02-22 2006-08-08 Genentech, Inc. Anti-interferon-α antibodies
CN1405181A (zh) * 2001-08-10 2003-03-26 中国人民解放军军事医学科学院生物工程研究所 血清白蛋白与干扰素的融合蛋白
US20070081995A1 (en) * 2005-06-22 2007-04-12 Genentech, Inc. Methods and compositions for targeting IFNAR2
JP5104622B2 (ja) * 2008-07-29 2012-12-19 Ｊｎｃ株式会社 磁性粒子を用いた測定対象物質の濃度測定法
AU2013211059B8 (en) * 2012-01-20 2017-12-21 Centre Hospitalier Regional Universitaire De Montpellier Targeted mutant alpha-helical bundle cytokines
ES2950288T3 (es) * 2016-04-29 2023-10-06 Pfizer Anticuerpos interferón beta y usos de los mismos

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3247922A1 (de) * 1982-12-24 1984-06-28 Boehringer Ingelheim International GmbH, 6507 Ingelheim Dna-sequenzen, deren herstellung, diese sequenzen enthaltende plasmide und deren verwendung zur synthese eukaryotischer genprodukte in prokaryoten
FR2653445B1 (fr) * 1989-10-20 1994-07-29 Centre Nat Rech Scient Fragment d'adnc codant pour le gene du recepteur de l'interferon alpha et procede de preparation d'une proteine correspondante.
AU653937B2 (en) * 1991-04-17 1994-10-20 Medisup International N.V. Water-soluble polypeptides having high affinity for interferons alpha and beta
RU2006036C1 (ru) * 1991-12-27 1994-01-15 Научно-исследовательский институт эпидемиологии и микробиологии им.Н.Ф.Гамалеи РАМН Способ определения антигенов
IL106591A (en) * 1992-09-03 2008-03-20 Yeda Res & Dev Interferon alpha/beta binding protein, its preparation and pharmaceutical compositions containing it

Also Published As

Publication number Publication date
JPH07298886A (ja) 1995-11-14
EP0676413B1 (en) 2005-01-05
CN1286976C (zh) 2006-11-29
CA2141747A1 (en) 1995-08-08
PT676413E (pt) 2005-05-31
FI950516A0 (fi) 1995-02-06
EP0676413B9 (en) 2005-05-18
CN1109505A (zh) 1995-10-04
JP2005200422A (ja) 2005-07-28
RU2362781C2 (ru) 2009-07-27
FI118084B (fi) 2007-06-29
NO950420D0 (no) 1995-02-06
RU2004106773A (ru) 2005-08-10
ZA95968B (en) 1995-10-10
ES2236696T3 (es) 2005-07-16
RU2004106774A (ru) 2005-08-10
RU2004106775A (ru) 2005-08-10
RU2232811C2 (ru) 2004-07-20
RU2336279C2 (ru) 2008-10-20
RU2363705C2 (ru) 2009-08-10
DE69533905T2 (de) 2005-12-29
EP0676413A3 (en) 1996-04-03
NO318912B1 (no) 2005-05-23
ATE286509T1 (de) 2005-01-15
UA46694C2 (uk) 2002-06-17
KR950032620A (ko) 1995-12-22
JP3670045B2 (ja) 2005-07-13
CA2141747C (en) 2012-05-01
DE69533905D1 (de) 2005-02-10
AU1141695A (en) 1995-08-17
AU688430B2 (en) 1998-03-12
KR100382628B1 (ko) 2004-02-25
EP0676413A2 (en) 1995-10-11
FI950516L (fi) 1995-08-08
IL108584A (en) 2008-03-20
IL108584A0 (en) 1994-05-30
NO950420L (no) 1995-08-08

Similar Documents

Publication Publication Date Title
DE69131580D1 (de) GDF-1 und UOG1 Proteine
NO950939L (no) Defektive adenovirusvektorer og deres anvendelse i gene-terapien
FI971613A7 (fi) Defektiivisiä adenoviruksia, jotka käsittävät terapeuttisen geenin ja immunoprotektiivisen geenin
MY102472A (en) Preparation of funtional human urokinase proteins.
EP0670730A4 (en) FUSION PROTEINS COMPRISING A TUMOR NECROSIS FACTOR RECEPTOR.
DK216589A (da) Dna sekvenser, rekombinante dna molekyler samt fremgangsmaader til fresmtilling af oploeselige t4-proteiner
FI962247L (fi) Uudet apoptoosia muuntavat proteiinit, niitä koodaava DNA ja näiden käyttömenetelmät
DK244289D0 (da) Fibronectinbindende protein, dets anvendelse og fremstilling samt midler til brug ved fremstillingen
EE200000152A (et) Aminoterminaalselt kärbitud MCP-2 vormid, DNA molekulid, ekspressioonivektor, peremeesrakk, rekombinantne meetod proteiini valmistamiseks, proteiini kasutamine ning farmatseutiline kompositsioon
ZA87141B (en) Dna sequences coding for proteins having the biological activity of husi-type i inhibitors,biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins
FI950516A0 (fi) Interferoni-alfa/beta-sitojaproteiini, sen valmistus ja käyttö
FI863626A7 (fi) DNA-sekvenssejä, yhdistelmä-DNA -molekyylejä ja menetelmiä ihmisen lip okortiinin kaltaisia polypeptidejä.
FI970097L (fi) Proteiinit, jotka ovat peräisin nisäkkäiden maksasta ja niiden käyttö onkologiassa
ATE128728T1 (de) Interferon-gamma bindende proteine.
DK0774002T3 (da) DNA, der koder for fåreadenovirus (oav287) og dets anvendelse som en viral vektor
AU590861B2 (en) New human lymphotoxin (TNF-beta) polypeptides their prepartion and use
DK0805204T3 (da) Bitestikel - specifikt receptorprotein og anvendelse heraf
DE69534738D1 (de) Leukocyten-aktivierender Faktor
ZA979390B (en) Polypeptides comprising domains of the GAX protein which are involved in the repression of transcription and/or which interact with other proteins, corresponding nucleic acids and their uses.
FI964784L (fi) Yhdistelmä-DNA-viruksia, valmistus ja käyttö geeniterapiassa
ATE332923T1 (de) Cr1 fragmente und deren verwendung
DK504286D0 (da) Protein med biologisk aktivitet svarende til humant interleukin-2, dets fremstilling og anvendelse
ATE342972T1 (de) Ifn rezeptor 1 bindende proteine, dafür kodierende dna und verfahren zur regulierung der zellulären antwort auf interferone
NO910331D0 (no) Rekombinant plasmid, fremgangsmaate til dets fremstilling og anvendelse av plasmidet i produksjonen av proteiner.
TH30275A (th) โปรตีนดัดแปลง